354 related articles for article (PubMed ID: 11120810)
1. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins.
Puente LG; Stone JC; Ostergaard HL
J Immunol; 2000 Dec; 165(12):6865-71. PubMed ID: 11120810
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
3. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells.
Roose JP; Mollenauer M; Gupta VA; Stone J; Weiss A
Mol Cell Biol; 2005 Jun; 25(11):4426-41. PubMed ID: 15899849
[TBL] [Abstract][Full Text] [Related]
4. Sustained TCR signaling is required for mitogen-activated protein kinase activation and degranulation by cytotoxic T lymphocytes.
Berg NN; Puente LG; Dawicki W; Ostergaard HL
J Immunol; 1998 Sep; 161(6):2919-24. PubMed ID: 9743353
[TBL] [Abstract][Full Text] [Related]
5. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
6. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
Whisler RL; Newhouse YG; Bagenstose SE
Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step.
Boyer C; Auphan N; Luton F; Malburet JM; Barad M; Bizozzero JP; Reggio H; Schmitt-Verhulst AM
Eur J Immunol; 1991 Jul; 21(7):1623-34. PubMed ID: 1829410
[TBL] [Abstract][Full Text] [Related]
8. Role of diacylglycerol (DAG) in hormonal induction of S phase in hepatocytes: the DAG-dependent protein kinase C pathway is not activated by epidermal growth factor (EGF), but is involved in mediating the enhancement of responsiveness to EGF by vasopressin, angiotensin II, and norepinephrine.
Dajani OF; Sandnes D; Melien O; Rezvani F; Nilssen LS; Thoresen GH; Christoffersen T
J Cell Physiol; 1999 Aug; 180(2):203-14. PubMed ID: 10395290
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte unresponsiveness induced by prolonged treatment with immobilized anti-CD3 antibody. Association of impairment of cytolytic activity with temporary depletion of intracellular protein kinase C.
Sano S; Kiyotaki C; Tatsumi Y; Fujiwara H; Hamaoka T
J Immunol; 1989 Nov; 143(9):2797-805. PubMed ID: 2530277
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-dependent and -independent mechanisms of cloned murine T cell proliferation. The role of protein kinase C translocation and protein kinase C activity.
Kim DK; Lancki DW; Hui FH; Fitch FW
J Immunol; 1989 Jan; 142(2):616-22. PubMed ID: 2521351
[TBL] [Abstract][Full Text] [Related]
11. Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression.
Pardo J; Buferne M; MartÃnez-Lorenzo MJ; Naval J; Schmitt-Verhulst AM; Boyer C; Anel A
Int Immunol; 2003 Dec; 15(12):1441-50. PubMed ID: 14645153
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells.
Denys A; Hichami A; Maume B; Khan NA
Lipids; 2001 Aug; 36(8):813-8. PubMed ID: 11592732
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid and phorbol ester-mediated interference of mitogenic signaling via novel protein kinase C isoforms in pancreatic beta-cells (INS-1).
Wrede CE; Dickson LM; Lingohr MK; Briaud I; Rhodes CJ
J Mol Endocrinol; 2003 Jun; 30(3):271-86. PubMed ID: 12790799
[TBL] [Abstract][Full Text] [Related]
14. A novel PKC regulates ERK activation and degranulation of cytotoxic T lymphocytes: Plasticity in PKC regulation of ERK.
Puente LG; He JS; Ostergaard HL
Eur J Immunol; 2006 Apr; 36(4):1009-18. PubMed ID: 16552708
[TBL] [Abstract][Full Text] [Related]
15. Hyperosmolality induces activation of cPKC and nPKC, a requirement for ERK1/2 activation in NIH/3T3 cells.
Zhuang S; Hirai SI; Ohno S
Am J Physiol Cell Physiol; 2000 Jan; 278(1):C102-9. PubMed ID: 10644517
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: dependence on protein kinase C-zeta.
van Dijk M; Muriana FJ; van Der Hoeven PC; de Widt J; Schaap D; Moolenaar WH; van Blitterswijk WJ
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):693-9. PubMed ID: 9169602
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
[TBL] [Abstract][Full Text] [Related]
18. Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation.
Kumar A; Chambers TC; Cloud-Heflin BA; Mehta KD
J Lipid Res; 1997 Nov; 38(11):2240-8. PubMed ID: 9392422
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol-3-kinase regulates PKCtheta activity in cytotoxic T cells.
Puente LG; Mireau LR; Lysechko TL; Ostergaard HL
Mol Immunol; 2005 Jun; 42(10):1177-84. PubMed ID: 15829307
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways.
Osborn MT; Berry A; Ruberu MS; Ning B; Bell LM; Chambers TC
Oncogene; 1999 Oct; 18(42):5756-64. PubMed ID: 10523856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
